The American Diabetes Association advises clinicians of the potential for insulin overbasalization in the management of type 2 diabetes. Described as the titration of basal insulin beyond an appropriate dose, overbasalization increases risks for adverse effects such as hypoglycemia and weight gain without achieving the glycemic targets needed to optimally manage the disease. There is a need to determine the prevalence of and clinical factors that can lead to overbasalization. This study aimed to assess the prevalence of and characterize the patient variables associated with overbasalization in a family medicine practice.
Quantifying and Characterizing the Presence of Insulin Overbasalization in a Family Medicine Practice
R.M. is currently affiliated with Walmart Pharmacy, Indianapolis, IN.
D.S. is currently affiliated with WellMed at Haverford, Sun City Center, FL.
S.M. is currently affiliated with Samaritan Health Services, Corvallis, OR.
Autumn Stewart-Lynch, Rebekah Meyers, Dina Sidig, Sea-oh McConville, Lindsay Heiple; Quantifying and Characterizing the Presence of Insulin Overbasalization in a Family Medicine Practice. Clin Diabetes 2023; cd230044. https://doi.org/10.2337/cd23-0044
Download citation file: